Article
Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2
2020-09-11
Abstract excerpt
SARS-CoV-2 is a newly emergent coronavirus that causes COVID-19, which has adversely impacted human health and has led to a pandemic. There is an unmet need to develop therapies against SARS-CoV-2 due to its severity and lack of treatment options. A promising approach to combat COVID-19 is through the neutralization of SARS-CoV-2 by therapeutic antibodies. Previously, we described a strategy to rapidly identify an...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a999222a-74f3-580a-ab97-46701122aaa7
- DOI
- 10.21203/rs.3.rs-45225/v1
